|
15.3.2018 |
EN |
Official Journal of the European Union |
L 73/18 |
DECISION OF THE EEA JOINT COMMITTEE
No 145/2016
of 8 July 2016
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/367]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘gentamicin’ (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 correcting Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’ (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
|
‘— |
32016 R 0305: Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 (OJ L 58, 4.3.2016, p. 35), |
|
— |
32016 R 0312: Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 (OJ L 60, 5.3.2016, p. 3).’ |
Article 2
The texts of Implementing Regulations (EU) 2016/305 and (EU) 2016/312 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 9 July 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 8 July 2016.
For the EEA Joint Committee
The President
Bergdís ELLERTSDÓTTIR
(*1) No constitutional requirements indicated.